The global clinical chemistry analyzers market accounted for USD 9.9 billion in 2016 and is expected to grow at a CAGR of 5.5% during the forecast period. The increasing prevalence of chronic diseases, such as diabetes, is predicted to be one of the high impact rendering drivers of this market.